Search Results
Found 1 results
510(k) Data Aggregation
(168 days)
An Enzyme Linked Immunosorbant Assay (ELISA) for the semiquantitative detection of IgG antibodies to gliadin in human serum. Detection of these antibodies is an aid in diagnosis of certain gluten sensitive enteropathies such as celiac diseage and dermatitis herpetiformis.
An Enzyme Linked Immunosorbant Assay (ELISA) for the semiquantitative detection of IgG antibodies to gliadin in human serum.
This document is a 510(k) clearance letter from the FDA for a diagnostic device, the QUANTA Lite™ IgG Gliadin ELISA Kit. It doesn't contain the detailed study results or acceptance criteria you're asking for. The letter confirms that the device has been found substantially equivalent to a legally marketed predicate device, but it doesn't describe the studies proving its performance or the specific acceptance criteria.
Therefore, I cannot provide the requested information from this document. The document primarily focuses on the regulatory approval rather than the technical and clinical performance data.
Ask a specific question about this device
Page 1 of 1